4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-21-000097
President and CEO sold 18,333 shares at an average $49.76 ($912,176)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-01 | Sale : show line 1 in the form | −1,659 | $48.61 | $80,644 | 2,138,375 | I |
| 2021-11-01 | Sale : show line 2 in the form | −16,674 | $49.87 | $831,532 | 2,121,701 | I |
| Open-market sales · 18,333 sh · avg $49.76 · $912,176 | ||||||
Loading xslF345X03/wf-form4_163597513221470.xml…